Purple Biotech (PPBT) Enterprise Value (2014 - 2026)
Purple Biotech (PPBT) reported Enterprise Value of -$6.4 million for Q1 2026, up 2.9% year-over-year from -$6.2 million in Q1 2025, and up 32.88% quarter-over-quarter from -$9.6 million in Q4 2025.
Purple Biotech (PPBT) Enterprise Value (2014 - 2026) Analysis & Trends
Purple Biotech (PPBT) has 13 years of Enterprise Value data on file, last reported at -$6.4 million in Q1 2026.
- Enterprise Value for Q1 2026 came in at -$6.4 million, up 2.9% year-over-year; the trailing twelve-month figure through Mar 2026 was -$6.4 million (up 2.9% YoY), and the FY2025 annual result was -$8.3 million, down 7.58% from the prior year.
- Enterprise Value improved to -$6.4 million in Q1 2026 per PPBT's latest filing, from -$9.6 million in the prior quarter.
- Over five years, Enterprise Value peaked at -$6.3 million in Q3 2024 and troughed at -$39.5 million in Q1 2022.
- A 5-year average of -$16.1 million and a median of -$15.3 million in 2024 frame the typical range for Enterprise Value.
- The sharpest annual moves came in 2022 and 2025: Enterprise Value surged 67.45% in 2022, then sank 66.31% in 2025.
- A 5-year view of Enterprise Value shows it stood at -$15.3 million in 2022, then declined by 0.43% to -$15.3 million in 2023, then surged by 49.96% to -$7.7 million in 2024, then decreased by 24.73% to -$9.6 million in 2025, then jumped by 32.88% to -$6.4 million in 2026.
- Business Quant data shows PPBT's Enterprise Value at -$6.4 million in Q1 2026, -$9.6 million in Q4 2025, and -$10.5 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Enterprise Value (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | -32.30 Mn |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | -4.14 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | -286.70 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | -18.44 Mn |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | -2.77 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | -7.20 Mn |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | -7.25 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -584.73 Mn |
| 10 | Purple Biotech | 261.30 Mn | 254.88 Mn | - | -6.43 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -6.43 Mn |
| Dec 31, 2025 | -9.57 Mn |
| Sep 30, 2025 | -10.45 Mn |
| Jun 30, 2025 | -8.26 Mn |
| Mar 31, 2025 | -6.62 Mn |
| Dec 31, 2024 | -7.68 Mn |
| Sep 30, 2024 | -6.29 Mn |
| Jun 30, 2024 | -15.33 Mn |
| Mar 31, 2024 | -15.34 Mn |
| Dec 31, 2023 | -15.34 Mn |
| Sep 30, 2023 | -15.95 Mn |
| Jun 30, 2023 | -15.88 Mn |
| Mar 31, 2023 | -15.88 Mn |
| Dec 31, 2022 | -15.27 Mn |
| Sep 30, 2022 | -33.08 Mn |
| Jun 30, 2022 | -36.02 Mn |
| Mar 31, 2022 | -39.55 Mn |
| Dec 31, 2021 | -46.92 Mn |
| Sep 30, 2021 | -47.69 Mn |
| Jun 30, 2021 | -49.09 Mn |